Verastem, Inc.

VSTM XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

330M

Short interest (May 15)

20.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.31%

↓ 19.1%

Available Shares

↓ 34.8%

Price Chart

Company Overview

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001526119

Asset Type: CS

Market Data

Market Cap: $334,798,564

Employees: 102

Status: Active

Short Interest

Current Borrow Fee 0.31%

Range: 0.29% - 0.31%

Available Shares 4M

Range: 3.1M - 3.7M

Recent Changes

Fee Change: ↑ 5.3%

Available Change: ↑ 2.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime